Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144

(2020) Francisco Hernández-Walias et al.   Scientific Reports

Dolutegravir-associated hyperglycaemia in patients with HIV

(2020) Mohammed Lamorde et al.   Lancet HIV

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease

(2020) Ana Gonzalez-Cordon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

(2020) Sergio Serrano-Villar et al.   Lancet HIV

Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders

(2020) Emilio Antonio Francischetti et al.   HORMONE AND METABOLIC RESEARCH

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association

(2019) Matthew J. Feinstein et al.   CIRCULATION

Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia

(2019) Mehwish Younas et al.   Frontiers in Immunology

Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection

(2019) Raphael Veil et al.   AIDS

Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort

(2019) Haijiang Lin et al.   Lancet HIV

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study

(2018) Lene Ryom et al.   Lancet HIV

Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure

(2018) Raza M. Alvi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis

(2017) Jose Echecopar-Sabogal et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men

(2017) David B. Hanna et al.   JOURNAL OF INFECTIOUS DISEASES

Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients

(2017) María J. Villanueva-Millán et al.   Journal of the International AIDS Society

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms

(2016) Piotr Chruściel et al.   ATHEROSCLEROSIS

Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease

(2016) Lavinia Woodward et al.   BRITISH JOURNAL OF PHARMACOLOGY

Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors

(2016) Alison Castley et al.   PLoS One

High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression

(2015) Evguenia Krastinova et al.   JOURNAL OF INFECTIOUS DISEASES

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ

(2015) Alessandra Ruggiero et al.   EBioMedicine

Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men

(2014) Kerunne S. Ketlogetswe et al.   AIDS

Reciprocal Effects of Systemic Inflammation and Brain Natriuretic Peptide on Adiponectin Biosynthesis in Adipose Tissue of Patients With Ischemic Heart Disease

(2014) Alexios S. Antonopoulos et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial

(2014) JE Lake et al.   HIV MEDICINE

Reduction of the HIV Protease Inhibitor-Induced ER Stress and Inflammatory Response by Raltegravir in Macrophages

(2014) Xiaoxuan Zhang et al.   PLoS One

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection

(2013) Chris T. Longenecker et al.   AIDS

Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

(2013) N. T. Funderburg et al.   CLINICAL INFECTIOUS DISEASES

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

(2012) Grace A. McComsey et al.   AIDS

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

(2012) Esteban Martínez et al.   AIDS

Soluble CD14

(2012) Alex P. Reiner et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection

(2012) Theodoros Kelesidis et al.   JOURNAL OF INFECTIOUS DISEASES

Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

(2011) Netanya G. Sandler et al.   JOURNAL OF INFECTIOUS DISEASES

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

(2010) Esteban Martinez et al.   AIDS

Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection

(2010) Jason V Baker et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

(2010) Jacqueline Neuhaus et al.   JOURNAL OF INFECTIOUS DISEASES

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

(2009) Alexandra Calmy et al.   AIDS

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

(2009) Kimberly Y Smith et al.   AIDS

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima‐Media Thickness in HIV‐Infected Patients Receiving Antiretroviral Therapy

(2009) Allison C. Ross et al.   CLINICAL INFECTIOUS DISEASES

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

(2009) Signe Westring Worm et al.   JOURNAL OF INFECTIOUS DISEASES

Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity

(2008) J Hung et al.   INTERNATIONAL JOURNAL OF OBESITY